Atopic Eczema Significantly Increases Risk of Suicidal Thoughts, Major Study Reveals Dr. Kamal Kant Kohli18 Sept 2025 8:45 PM ISTA new international study presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that adults with atopic...
Hidradenitis Suppurativa Linked to Higher Risk of Serious Eye Diseases: Study Dr Riya Dave17 Sept 2025 9:30 PM ISTResearchers have determined in a new study that hidradenitis suppurativa (HS), a long-term inflammatory skin condition, is linked to an increased risk...
Psoriasis Treatments Show No Impact on Blood Glucose Levels: Study Dr. Shravani Dali16 Sept 2025 8:45 PM ISTA new study published in Dermatology just put to rest the idea that biologics or methotrexate might double as anti-diabetes medications for people...
Biologic Therapy may Lower Malignancy Risk in Psoriasis, suggests study Dr. Shravani Dali15 Sept 2025 8:30 PM ISTA new study has investigated the impact of biologic therapies on cancer risk among patients with psoriasis and found that these treatments may offer...
Maternal Dietary Diversity Lowers Childhood Eczema Risk: Study Jacinthlyn Sylvia14 Sept 2025 9:00 PM ISTA new study published in the journal of Pediatric Allergy and Immunology revealed that greater dietary diversity during pregnancy was associated...
AOPT-LTL Therapy Improves Melasma via SCF/c-KIT Pathway Inhibition: Study Finds Medha Baranwal12 Sept 2025 11:00 PM ISTChina: A new study has revealed that AOPT-LTL therapy significantly improves melasma by reducing melanogenesis, inflammation, angiogenesis, mast cell...
Psoriatic Arthritis Patients Face Higher Burden of Metabolic Syndrome, Meta-Analysis Shows Medha Baranwal12 Sept 2025 10:15 PM ISTSweden: A new meta-analysis published in Clinical Rheumatology highlights that individuals with psoriatic arthritis (PsA) face a significantly greater...
Oral vs. Topical TXA: Comparable Effectiveness and Safety in treatment of Melasma Dr. Shravani Dali12 Sept 2025 8:45 PM ISTMelasma is a chronic pigmentary disorder characterized by symmetric, hyperpigmented macules and patches on sun-exposed areas, most commonly the face....
Upadacitinib Shows Safety and Efficacy in Adolescents with Severe Alopecia Areata: Study Dr. Shravani Dali11 Sept 2025 8:15 PM ISTAlopecia areata (AA) is a chronic, immune-mediated disorder characterized by non-scarring hair loss, with profound psychological and social...
Melanoma Patients Face Greater Risk of Vitiligo, Psoriasis, and Other Autoimmune Conditions: Study Finds Medha Baranwal10 Sept 2025 9:00 PM ISTKorea: A large-scale population-based study from South Korea has revealed a significant association between melanoma and several autoimmune diseases,...
Methotrexate and TNF Inhibitors Linked to Lowest Cardiovascular Risk in Psoriasis: Study Dr. Shravani Dali9 Sept 2025 8:45 PM ISTPsoriasis is a chronic inflammatory disease that affects not only the skin but also systemic health, including cardiovascular risk. Recent research...
Baricitinib not linked to increased VTE Risk in Alopecia Areata Patients: Study Jacinthlyn Sylvia8 Sept 2025 8:30 PM ISTA new study published in the International Journal of Dermatology revealed that alopecia areata patients treated with baricitinib had no reported...
